The inaugural University of Exeter MRC CMM Mycology Partnerships Summit, held on November 12, 2025, was a resounding success, bringing together academia and industry to accelerate solutions in the field of medical mycology.
This fully funded in person and online event offered a dynamic platform for researchers, clinicians, and industry experts to share pioneering advances across drugs, diagnostics, immunotherapies, funding opportunities, clinical trials, and infection studies. Attendees from around the world engaged in cutting-edge discussions and interactive sessions designed to inspire new partnerships and collaborations.
Highlights of the day included the keynote address by Dr. Kieren Marr, President & CEO of Elion Therapeutics, who shared valuable insights into the challenges and opportunities facing medical mycology, focusing on innovative developments in drugs and diagnostics. Presentations on state-of-the-art research capabilities and updates on exciting funding and trial opportunities further energized the community.
The summit’s interactive programme successfully fostered connections among participants, providing a powerful catalyst to accelerate progress against fungal diseases. Feedback from attendees noted the value of expert discussions and the collaborative spirit that the summit encouraged.
For those interested in future participation to FAILSAFE and CMM events, attendance remains exclusive to CMM-FAILSAFE Medical Mycology members. Joining is free. Simply visit our dedicated joining page here and sign up.
Thank you to everyone who contributed to and participated in making the MRC CMM Mycology Partnerships Summit 2025 a memorable and impactful occasion. We look forward to building on this momentum in the years ahead
